MedPath

Evaluation of the effect of Methylphenidate on consciousness in patients ?with brain damage in IC

Phase 3
Conditions
Brain damage.
Unspecified brain damage due to birth injury
P11.2
Registration Number
IRCT20141209020258N128
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

A level of consciousness less than 10
Being intuitive
Ages between 16 and 50 years
History of brain injury
Absence of spacer lesion in brain scan (hematoma, tumor)
No history of seizures
No addiction to psychotropic substances and drugs
No history of amphetamine use
No history of hypertension, ischemic heart disease and diabetes mellitus
Heart rate less than 120 times per minute

Exclusion Criteria

Seizure
Arrhythmia
Death

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evel of consciousness. Timepoint: daily to clearance time. Method of measurement: Glasgow coma scale.;Illness severity. Timepoint: First and third day and time of discharge. Method of measurement: Apache score.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath